Moderate riskFDA DrugClass III

Radnostix Gelatin Capsule Pack recalled for failed capsule specifications

Radnostix Gelatin Capsule Packs used with Sodium Iodide I-131 Kit have failed quality specifications. The affected capsules may not perform as intended. Three specific lots distributed nationwide are involved.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Radnostix Gelatin Capsule Pack Lot 3666245, 4546213, or 4951280
  2. Stop using affected capsules immediately
  3. Contact your healthcare provider or pharmacy for instructions on next steps

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
2,699 blister cartons
Illnesses reported
None reported
Manufactured in
4137 Commerce Cir, Idaho Falls, ID, United States
Classification
Class III
Recall number
D-0401-2026

In the FDA's words

Description
Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35 Failed Tablet/Capsule Specifications Lot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027 Distribution: Nationwide in the US, including Puerto Rico Affected quantity: 2,699 blister cartons
Hazard
Failed Tablet/Capsule Specifications

Related topics

PotencyDrugsSold nationwideMore from FDA Drug